- Zacks Small Cap Research•2 months ago
Revenue came in at ~$400,000 but widely missed our estimate by ~50%. The domestic market (Canada) revenue decreased ~50% as compared to the same period in 2015 offsetting more than ~50% bump in international regions. The U.S. revenue jumped by 1700% from Q1 2015. Theralase is focused on training its marketing team to grow its U.S. revenues as well as international revenues through exclusive distribution agreements.
- Capital Cube•11 months ago
Theralase Technologies, Inc. reports preliminary financial results for the quarter ended June 30, 2015.We analyze the earnings along side the following peers of Theralase Technologies Inc. – Pyng Medical Corp., Verisante Technology, Inc., Medx Health Corp. and CRH Medical Corporation (PYT-CA, VRS-CA, MDX-CA and CRH-CA) that have also reported for this period.HighlightsSummary numbers: Revenues of […] (Read more...) The post Theralase Technologies, Inc. Earnings Q2, 2015 appeared first on CapitalCube.
|52wk Range||0.25 - 0.45|
|Day's Range||0.41 - 0.44|
|Avg Vol (3m)||134,390|
As of 3:59 PM EDT. Market closed.